Barriers to delivery of thrombolysis for acute stroke

Age and Ageing

Volumn 33, Issue 2, 2004, Pages 94-95

  Barber, Mark ^a   Langhorne, Peter ^a   Stott, David J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL PRACTICE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; ELDERLY CARE; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; FIRST AID; HEALTH CARE DELIVERY; HEALTH PRACTITIONER; HOSPITAL ADMISSION; HUMAN; LICENSING; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RISK REDUCTION; STROKE; SYMPTOMATOLOGY; UNITED KINGDOM;

AGED; CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC AGENTS; HUMANS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 1542299722     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/afh065     Document Type: Editorial

References (13)

1. Kwan J, Hand P, Sandercock P. A systematic review of barriers to delivery of thrombolysis for acute stroke. Age Ageing 2004; 33: 116-121.
2. Harraf F, Sharma AK, Brown MM, Lees KR, Vass RI, Kalra L. A multicentre observational study of presentation and early assessment of acute stroke. Br Med J 2002; 325: 17-21.
3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
4. Lenzer J. Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign. Br Med J 2002; 324: 723-6.
5. Ingall TJ, O'Fallon WM, Louis TA, Hertzberg V, Goldfrank LR, Asplund K. Initial findings of the rt-PA acute stroke treatment review panel. Cerebrovascular Dis 2003; 16: 125 [Abstract].
6. Wardlaw JM, del Zoppo GJ, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke (Cochrane Review). The Cochrane Library, Issue 3. Oxford: Update Software, 2003.
7. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 1997; 28: 957-60.
8. Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001; 32: 438-41.
9. Stroke Units Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke (Cochrane Review). The Cochrane Library, Issue 3. Oxford: Update Software, 2003.
10. Langhorne P, Pollock A. What are the components of effective stroke unit care? Age Ageing 2002; 31: 365-71.
11. Davis M, Hollymann C, McGiven M, Chambers I, Egbuji J, Barer D. Physiological Monitoring in Acute Stroke. Age Ageing 1999; 28 (Suppl 1): 45 [Abstract].
12. Langhorne P, Fraser P, Wright F, Shields M, MacIntosh G, Stott D. Evaluation of an Acute Care Protocol for Stroke Patients: A Controlled Clinical Trial. Age Ageing 2001; 11 (Suppl 4): 128 [Abstract].
13. Sulter G, Elting JW, Langedijk M, Maurits NM, De Keyser J. Admitting Acute Ischemic Stroke Patients to a Stroke Care Monitoring Unit Versus a Conventional Stroke Unit: A Randomized Pilot Study. Stroke 2003; 34: 101-4.